Trial intelligence / Profile preview

Low dose Vitamin K for INR control in warfarin patients

NCT00990158Phase 3Completed

Sponsor
St. Joseph's Healthcare Hamilton
Start
Jul 2010
Primary completion
Apr 2014
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of phytomenadione in thromboembolism, sponsored by St. Joseph's Healthcare Hamilton. Started Jul 2010; status: completed.

02

Drugs

phytomenadione
03

Conditions

thromboembolism

Beyond the preview

Go deeper on NCT00990158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00990158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call